Company Profile
In 2006, Shanghai Haoyuan Chemexpress Co., Ltd. is located in the famous Zhangjiang Biopharmaceutical High-tech Campus in Shanghai, China. We focus on supplying products and services to our clients in the field of small molecule drug discovery. In the past one and a half decades, our molecular building blocks, chemical and biochemical reagents, reference compounds, and custom synthesis services have helped hundreds of academicians and pharmaceutical enterprises to move forward with their drug discovery projects along different pipelines. Based on our strong process chemistry R&D platform, we have served global pharmaceutical enterprises and research institutions with a large scale pharmaceutical intermediate and APIs accompanied by technical services. The company was granted Innovative Professional Enterprise and “Small Giant Enterprise” models among hundreds of enterprises in Shanghai. The company was honorably appointed as “City Brand Incubation and Demonstration Enterprises” and “Pilot Patent Respecting Enterprises” of Shanghai. Chemexpress has been fast-growing in the field of biomedicine, adhering to scientific and technological innovation by challenging and solving refractory difficulties of our clients. After one and a half decades of technical accumulation and industrial experience, Chemexpress has built platforms for the research, development and manufacturing of highly potent APIs (HPAPIs), vitamin D derivatives and generic pharmaceutical APIs, as well as target-specific drugs. The R&D platforms for solid-state physical-chemical investigation, complex chiral molecule study, and building blocks and reference compounds are based on several core technologies developed in-house. These platforms are integrated to cover services for pharmaceutical clients working on the development of therapeutics for anti-tumor, anti-virus, diabetes, cardiovascular, immune diseases and other areas of diseases. To maintain a high innovation efficiency, the company has continuously increased the investment on R&D facilities and state-of-the-art equipment in the past several years, including the establishment of kilogram GMP conditions plants and R&D centers. We have also established business centers in Hong Kong and the United States of America. Our people are the core value of the company. Our talent-driven innovation teams have brought about many core technologies, including 100 patent applications and much more. The company has also won the regulatory identification of the R&D Enterprise Institution of Pudong New District of Shanghai. Chemexpress adheres to our vision, our mission, and our value, keeping abreast of the current trend and state-of-the-art science and technologies of the global biopharmaceutical industry to serve our clients to the utmost satisfaction. Our existing advantages have led to our in-depth services for the R&D of small molecule drug discovery. At present, Chemexpress has a life-cycle collaboration with a few dozens of most prestigious pharmaceutical and health care companies, research institutes, and CROs in Asia, Europe, the USA, Oceania, etc., and has successfully delivered innovative R&D products and services to more than 3,000 partners across the world. Our goal is to become a world-class leading company to support life science innovation and manufacturing.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
((1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) |
1H-Indene, 4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-, (1R,3aS,4E,7aR)-;(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-1H-indene;[[(1a,3b,5E,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethylsilane];((1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-7a-Methyl-1-((R)-6-Methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane) |
112670-85-6 | Inquiry | |
((2R,3S)-3-(tert-butyldiphenylsilyloxy)-2,3-dihydrofuran-2-yl)methanol |
((2R,3S)-3-(tert-butyldiphenylsilyloxy)-2,3-dihydrofuran-2-yl)methanol;[(2R,3S)-3-[tert-butyl(diphenyl)silyl]oxy-2,3-dihydrofuran-2-yl]methanol;[(2R,3S)-3-(tert-butyl(diphenyl)silyl)oxy-2,3-dihydrofuran-2-yl]methanol;SCHEMBL867354;CS-M0014;ZINC195867800;D-erythro-Pent-1-enitol,1,4-anhydro-2-deoxy-3-O-[(1,1-dimethylethyl)diphenylsilyl]-;CS-14149;3beta-(tert-Butyldiphenylsiloxy)-2,3-dihydrofuran-2alpha-methanol;((2R,3S)-3-((tert-butyldiphenylsilyl)oxy)-2,3-dihydrofuran-2-yl)methanol |
130277-32-6 | Inquiry | |
(+)-(S)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric acid |
1-Piperidinebutanoic acid,4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]-;4-[(S)-(4-Chlorophenyl)-2-pyridinylmethoxy]-1-piperidinebutanoic acid;Bepotastine;(S)-Bepotastine;(S)-4-[4-(4-chlorophenyl-2-pyridylmethoxy)piperidinyl]butyric acid;190786-43-7 |
125602-71-3 | Inquiry | |
(+)-JQ-1 |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid,4-(4-chlorophenyl)-2,3,9-trimethyl-,1,1-dimethylethyl ester,(6S)-;1,1-Dimethylethyl (6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetate;(+)-JQ 1;JQ 1;(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate;JQ1 (pharmaceutical);JQ 1(+);tert-Butyl (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate;(S)-JQ1;JQ1 (BET inhibitor);BET domain inhibitor JQ1;Bromodomain and extra-terminal domain inhibitor JQ1 |
1268524-70-4 | Inquiry | |
(-)-Blebbistatin |
(-)-BLEBBISTATIN;4H-Pyrrolo[2,3-b]quinolin-4-one, 1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-, (3aS)-;(+/-)-BLEBBISTATIN;(S)-(-)-BLEBBISTATIN;(-)-Blebbistatin - CAS 856925-71-8 - Calbiochem;(3aS)-3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one;CS-978;3a-Hydroxy-6-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one (-)-Blebbistatin |
856925-71-8 | Inquiry | |
(-)-Epigallocatechin Gallate |
Benzoic acid,3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester;Epigallocatechol,3-gallate,(-)-;Benzoic acid,3,4,5-trihydroxy-,3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester,(2R-cis)-;Epigallocatechol,3-gallate;Epigallocatechol,gallate;Gallic acid,3-ester with epigallocatechol,(-)-;(-)-Epigallocatechin gallate;(-)-Epigallocatechol gallate;(-)-Epigallocatechin 3-gallate;Epigallocatechin gallate;Epigallocatechin 3-gallate;3-O-Galloyl-(-)-epigallocatechin;(-)-Epigallocatechin 3-O-gallate;L-Epigallocatechin gallate;epi-Gallocatechin 3-O-gallate;(-)-epi-Gallocatechin 3-O-gallate;NVP-XAA 723;Epigallocatechin 3-O-gallate;Epigallocatechin-3-monogallate;Teavigo;PF-EGCg 90;EGCG;epi-Gallocatechin gallate;Theliokeep;Teafuran 90S;EGCg-OP;863-65-0;435276-52-1 |
989-51-5 | Inquiry | |
(-)-Huperzine A |
5,9-Methanocycloocta[b]pyridin-2(1H)-one,5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-,(5R,9R,11E)-;5,9-Methanocycloocta[b]pyridin-2(1H)-one,5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-,[5R-(5α,9β,11E)]-;Selagine;(5R,9R,11E)-5-Amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one;Huperzine A;(-)-Huperzine A;(-)-Selagine;Kimpukan A;Hupzine A;Hup A;Huperzine;116-28-9;1369-64-8;475473-11-1 |
102518-79-6 | Inquiry | |
(1-benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate |
(1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate;p-Toluenesulfonic acid (1-benzyl-4-cyano-4-piperidyl)methyl ester;(1-benzyl-4-cyanopiperidin-4-yl)Methyl 4-Methylbenzene-1-sulfonate |
270257-39-1 | Inquiry | |
(1R,2S)-methyl 2-hydroxycyclopentanecarboxylate |
(1R,2S)-methyl 2-hydroxycyclopentanecarboxylate;CS-M0787;ZINC34239674;AKOS006372032;cis-Methyl 2-hydroxycyclopentanecarboxylate;2beta-Hydroxycyclopentane-1beta-carboxylic acid methyl ester;METHYL (1R,2S)-2-HYDROXYCYCLOPENTANE-1-CARBOXYLATE;(A+/-)-cis-2-hydroxy-cyclopentanecarboxylic acid methyl ester |
122331-02-6 | Inquiry | |
(1r,4r)-4-hydroxycyclohexanecarboxylic acid |
Cyclohexanecarboxylic acid,4-hydroxy-,trans-;trans-4-Hydroxycyclohexanecarboxylic acid;trans-4-Hydroxycyclohexylcarboxylic acid;(1r,2r)-4-Hydroxycyclohexan-1-carboxylic acid |
3685-26-5 | Inquiry | |
(1S,2R)-methyl 2-(4-bromobenzoyl)cyclopentanecarboxylate,CIS |
(1S,2R)-Methyl 2-(4-broMobenzoyl)cyclopentanecarboxylate,CIS;(+/-)-CIS-2-(4-BROMO-BENZOYL)-CYCLOPENTANECARBOXYLIC ACID METHYL ESTER;Methyl cis-2-(4-bromobenzoyl)cyclopentanecarboxylate |
791594-11-1 | Inquiry | |
(1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid |
Cyclopenta[c]pyrrole-1-carboxylic acid,(2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyloctahydro-,(1S,3aR,6aS)-;Cyclopenta[c]pyrrole-1-carboxylic acid,(2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyloctahydro-,(1S,3aR,6aS)-;(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyloctahydrocyclopenta[c]pyrrole-1-carboxylic acid |
402958-98-9 | Inquiry | |
(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol |
BIS-TBDMS-TRANS-CALCIPOTRIOL;24-Cycloproyply-1,3-bis[[(1,1-dimethylethyl)dimethylsily]oxy]-9,10-secochola-5,7,10(19),22-tetraen-24-ol;Cyclopropanemethanol, a-[(1E,3R)-3-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-buten-1-yl]-, (aS)-;Trans-Calcipotriol-bis-TBDMS-ether;Bis-O-(tert-butyldimethylsilyl)-trans-calcipotriol;(αS)-α-[(1E,3R)-3-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]-1-buten-1-yl]cyclopropaneMetha;(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol;Calcipotriol Impurity 10 |
112849-27-1 | Inquiry | |
(±)-Huperzine A |
5,9-Methanocycloocta[b]pyridin-2(1H)-one,5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-,(11E)-;5,9-Methanocycloocta[b]pyridin-2(1H)-one,5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-,(5α,9β,11E)-(±)-;(11E)-5-Amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one;(±)-Huperzine A;5,9-Methanocycloocta[b]pyridin-2(1H)-one,5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-,(5α,9β,11E)-;Fordine;103735-86-0;912960-35-1;687989-75-9 |
120786-18-7 | Inquiry | |
4-Nonylphenol polyethoxylate |
Poly(oxy-1,2-ethanediyl),α-(4-nonylphenyl)-ω-hydroxy-;Glycols,polyethylene,mono(p-nonylphenyl) ether;Phenol,p-nonyl-,monoether with polyethylene glycol;α-(p-Nonylphenyl)-ω-hydroxypoly(oxyethylene);Polyethylene glycol p-nonylphenyl ether;Polyethylene glycol mono(p-nonylphenyl) ether;Tetra(oxyethylene),α-(4-nonylphenyl)-ω-hydroxy-;p-Nonylphenol-polyethylene glycol adduct;Ethoxylated p-nonyl phenol;Polyethylene glycol mono(4-nonylphenyl) ether;Nonoxynol;p-Nonylphenol polyethylene glycol ether;Rokafenol NX 8;Nonoxynol 13;Nonoxynol 6;Nonoxynol 14;Nonoxynol 10;Rokafenol N 25;Rokafenol N;Rokafenol N 10;Rokafenol N 8;Rokafenol N 4;Rokafenol N 5;Rokafenol N 14;Rokafenol N 6;Rexol 25/6;Polyethylene glycol 4-nonylphenyl monoether;Newcol 565;Bion NE 9;Nonoxynol 9;Rokafenol N 2;Rokafenol N 45;Delfen;Conceptrol;Encare oval;NOP 8;NOP 17;Egyptol;Koromex;Prevocell W-ON 100;Rokafenol N 3;Praewozell W-ON 100;N 100;Polyoxyethylene p-nonylphenyl ether;Gynol II;Iconol NP 100;Akyporox NP 150;Liponox NCY;PEG p-nonylphenyl ether;W-ON 100;Polyethylene glycol-10 p-nonylphenol ether;p-Nonylphenyl polyoxyethylene ether;Pannox 16;Pannox 18;Pannox 110;Pannox 111;Pannox 116;Pannox 140;Pannox 150;NP 8.5;Polyoxyethylene mono-p-nonylphenyl ether;Poly(oxyethylene)-4-nonylphenyl ether;Nonoxynol 8.5;Imbetin N 7A;APSA 80;Amway All Purpose Spray Adjuvant;Amway APSA 80;Hyoxyd X 400;Nonoxynol 15;Monopol NP 1013;9002-95-3;12612-63-4;27942-26-3;28776-15-0;29319-48-0;34149-89-8;37330-04-4;39042-04-1;52440-21-8;52440-22-9;55247-80-8;56214-26-7;58339-76-7;68858-84-4;69154-14-9;70025-66-0;78009-08-2;86243-62-1;86727-29-9;96827-50-8;96827-63-3;99550-41-1;100777-03-5;102735-76-2;113595-38-3;117989-54-5;120038-12-2;124401-72-5;131160-29-7;135229-74-2;190386-13-1;195065-75-9;204842-55-7;226924-41-0;374934-72-2;1338788-01-4 |
26027-38-3 | Inquiry | |
Calcipotriol Impurity C |
1,3-Cyclohexanediol,5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-,(1S,3S,5E)-;9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol,24-cyclopropyl-,(1α,3β,5E,7E,22E,24S)-;(1S,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-Cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol;PRI 2205;5,6-trans-Calcipotriol |
113082-99-8 | Inquiry | |
Hexetidine |
5-Pyrimidinamine,1,3-bis(2-ethylhexyl)hexahydro-5-methyl-;Pyrimidine,5-amino-1,3-bis(2-ethylhexyl)hexahydro-5-methyl-;1,3-Bis(2-ethylhexyl)hexahydro-5-methyl-5-pyrimidinamine;5-Amino-1,3-bis(2-ethylhexyl)hexahydro-5-methylpyrimidine;5-Amino-1,3-bis(β-ethylhexyl)-5-methylhexahydropyrimidine;5-Amino-1,3-bis(2-ethylhexyl)-5-methylhexahydropyrimidine;5-Amino-1,3-di(β-ethylhexyl)hexahydro-5-methylpyrimidine;1,3-Bis(β-ethylhexyl)-5-methyl-5-aminohexahydropyrimidine;Hexetidine;Sterilate;Sterisil;Triscol;Hextril;Oraldene;Hexoral;Glypesin;Triocil;Steri/Sol;Elsix;Hexigel;Hexocil;NSC 17764;Hexopyrimidine |
141-94-6 | Inquiry | |
Hexylene glycol |
2,4-Pentanediol,2-methyl-;2-Methyl-2,4-pentanediol;2,4-Dihydroxy-2-methylpentane;Diolane;Hexylene glycol;Isol;α,α,α′-Trimethyltrimethylene glycol;1,1,3-Trimethyltrimethylenediol;MPD;(±)-2-Methyl-2,4-pentanediol;NSC 8098;Hexasol;Isohexanediol;99113-75-4 |
107-41-5 | Inquiry | |
Hexylresorcinol |
1,3-Benzenediol,4-hexyl-;Resorcinol,4-hexyl-;4-Hexyl-1,3-benzenediol;S.T. 37;Caprokol;Crystoids;Cystoids Anthelmintic;4-Hexyl-1,3-dihydroxybenzene;4-Hexylresorcine;Hexylresorcinol;p-Hexylresorcinol;4-Hexylresorcinol;Sucrets;4-n-Hexylresorcinol;1,3-Dihydroxy-4-hexylbenzene;Adrover;Hidesol;Antascarin;Ascaricid;Oxana;Ascarinol;Prensol;4-(1-Hexyl)resorcinol;1-(2′,4′-Dihydroxyphenyl)hexane;Mycoderm;EverFresh;KOM 14;Worm-Agen;Gelovermin;Ascaryl;NSC 1570;Synovea HR |
136-77-6 | Inquiry | |
Histamine |
1H-Imidazole-5-ethanamine;Histamine;1H-Imidazole-4-ethanamine;Eramin;Ergamine;Ergotidine;5-Imidazoleethylamine;Imidazole-4-ethylamine;β-Imidazolyl-4-ethylamine;2-(4-Imidazolyl)ethylamine;4-(2-Aminoethyl)imidazole;2-(1H-Imidazol-4-yl)ethylamine;2-(4-Imidazolyl)ethanamine;2-(1H-Imidazol-5-yl)ethylamine;2-(1H-Imidazol-4-yl)ethanamine;NSC 33792;2-(1H-Imidazol-5-yl)ethanamine;2-(3H-Imidazol-4-yl)ethylamine;2-(1H-Imidazol-5-yl)ethan-1-amine;2-(1H-Imidazol-4-yl)ethan-1-amine;64422-25-9;924364-91-0;1416954-63-6 |
51-45-6 | Inquiry |